Inactive Instrument
Albany Molecular Research, Inc. Stock
Equities
US0124231095
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Philip W Macnabb
CEO | Chief Executive Officer | - | 2023-04-30 |
Gerald Auer
DFI | Director of Finance/CFO | - | 2023-12-31 |
Meera Khullar
CMP | Compliance Officer | - | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Cunningham
BRD | Director/Board Member | 50 | - |
William McMullan
BRD | Director/Board Member | 48 | - |
Maria Hilado
BRD | Director/Board Member | 61 | 2021-08-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.09% | - | - | 0 | ||
| +1.74% | +0.55% | -1.64% | -9.59% | 45.62B | ||
| -1.20% | -0.36% | +34.42% | +22.90% | 34.34B | ||
| -0.89% | +2.25% | +28.92% | +27.68% | 29.46B | ||
| -0.97% | -3.42% | +14.97% | -16.20% | 28.09B | ||
| +0.22% | -2.71% | +169.96% | +361.83% | 19.11B | ||
| -1.01% | +4.38% | +58.47% | +198.43% | 14.78B | ||
| +2.31% | -6.43% | +2,918.75% | +3,811.51% | 14.25B | ||
| -1.59% | -0.97% | +65.77% | +157.65% | 14.09B | ||
| +0.25% | -4.10% | +35.07% | +2.59% | 13.25B | ||
| Average | -0.11% | -1.23% | +369.41% | +506.31% | 23.67B | |
| Weighted average by Cap. | -0.06% | -0.80% | +232.30% | +315.17% |
















